 MALVERN, Pa., May 09, 2022 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy, today announced that the Company will participate in the 2022 H.C. Wainwright Annual Global Investment Conference on May 24th, 2022. 